Evidence map›Paper›PMID 18945672›Full record

ArticleThe Journal of biological chemistry2008

Thymine DNA glycosylase represses myocardin-induced smooth muscle cell differentiation by competing with serum response factor for myocardin binding.

Jiliang Zhou, Emily K Blue, Guoqing Hu, B Paul Herring

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Circulation · 2021
    Article
  5. Article
  6. Article
  7. Article
  8. Thymine DNA glycosylase is a key regulator of CaMKIIγ expression and vascular smooth muscle phenotype.American journal of physiology. Heart and circulatory physiology · 2019
    Article
  9. Myocardin in biology and disease.Journal of biomedical research · 2015
    Review
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Jiliang ZhouCenter for Cardiovascular Sciences, Albany Medical College, Albany, New York 12208, USA. zhouj1@mail.amc.edu
Emily K Blue
Guoqing Hu
B Paul Herring
Albany Medical Center Hospital · USIndiana University – Purdue University Indianapolis · USIndiana University School of Medicine

Funding

RESEARCH TRAINING PROGRAM IN DIABETES AND OBESITYT32DK064466 · NIDDK · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI Carmella Evans-Molina, RONALD C WEK · 2003 to 2026
$5.2M
Visceral smooth muscle-specific gene expressionR01DK061130 · NIDDK · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI HERRING, BRIAN PAUL · 2001 to 2011
$2.8M
Synthetic smooth muscle cell-selective promotersR01DK065644 · NIDDK · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI HERRING, BRIAN PAUL · 2004 to 2006
$851k
NIDDK NIH HHS DK064466NIDDK NIH HHS DK61130NIDDK NIH HHS DK65644NIDDK NIH HHS R01 DK061130
6 · The paper itself

Abstract

Myocardin is a serum response factor (SRF) co-activator that regulates transcription of many smooth muscle-specific genes and is essential for development of vascular smooth muscle. We used a yeast two-hybrid screen, with myocardin as bait in a search for factors that regulate myocardin transcriptional activity. From this screen, thymine DNA glycosylase (TDG) was identified as a myocardin-associated protein. TDG was originally identified as an enzyme involved in base excision repair of T:G mismatches caused by spontaneous deamination of methylated cytosines. However, TDG has also been shown to act as a transcriptional co-activator or co-repressor. The interaction between TDG and myocardin was confirmed in vitro by glutathione S-transferase pull down and in vivo by co-immunoprecipitation assays. We found that TDG abrogates myocardin induced expression of smooth muscle-specific genes and represses the trans-activation of the promoters of myocardin of these genes. Overexpression of TDG in SMCs down-regulated smooth muscle marker expression. Conversely, depletion of endogenous TDG in SMCs increased smooth muscle-specific myosin heavy chain (SM MHC) and Telokin gene expression. Glutathione S-transferase pull-down assays demonstrated that TDG binds to a region of myocardin that includes the SRF binding domain. Furthermore, TDG was found to compete with SRF for binding to myocardin in vitro and in vivo, suggesting that TDG can inhibit expression of smooth muscle-specific genes, at least in part, through disrupting SRF/myocardin interactions. Finally, we demonstrated that the glycosylase activity of TDG is not required for its inhibitory effects on myocardin function. This study reveals a previously unsuspected role for the repair enzyme TDG as a repressor of smooth muscle differentiation via competing with SRF for binding to myocardin.

Indexed as

AnimalsBase SequenceCell DifferentiationCell LineMiceMolecular Sequence DataMyocardinNuclear ProteinsProtein BindingRatsRepressor ProteinsSerum Response FactorThymine DNA GlycosylaseTrans-ActivatorsTwo-Hybrid System TechniquesMyocardinNuclear ProteinsRepressor ProteinsSerum Response FactorThymine DNA GlycosylaseTrans-Activators

Identifiers

PMID18945672
PMCPMC2602901
OpenAlexW2027990026

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.